Nephroprotection by antifibrotic and anti-inflammatory effects of the vasopeptidase inhibitor AVE7688

Effects of Losartan on Renal and Cardiovascular Outcomes in Patients with Type 2 Diabetes and Nephropathy

Barry M. Brenner, Mark E. Cooper, Dick de Zeeuw et al. · New England Journal of Medicine · 2001 · 7.5K citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Renoprotective Effect of the Angiotensin-Receptor Antagonist Irbesartan in Patients with Nephropathy Due to Type 2 Diabetes

Edmund J. Lewis, Lawrence G. Hunsicker, William R. Clarke et al. · New England Journal of Medicine · 2001 · 6K citations · Full text

Medicine, Nephrology, Pharmacology +16

Randomised controlled trial of dual blockade of renin-angiotensin system in patients with hypertension, microalbuminuria, and non-insulin dependent diabetes: the candesartan and lisinopril microalbuminuria (CALM) study

C. E. Mogensen, Steen Neldam, I. Tikkanen et al. · BMJ · 2000 · 1K citations · Full text

Pharmacy, Internal Medicine, Pharmacotherapy +17

HEREDITARY FAMILIAL CONGENITAL HAEMORRHAGIC NEPHRITIS

A. Cecil Alport · BMJ · 1927 · 666 citations · Full text

Medicine, Genetics, Nephrology +12

Renal function and requirement for dialysis in chronic nephropathy patients on long-term ramipril: REIN follow-up trial

Piero Ruggenenti, Annalisa Perna, Giulia Gherardi et al. · The Lancet · 1998 · 574 citations

Medicine, Nephrology, Pharmacotherapy +11